Insider Trading June 29, 2026 09:13 PM

Schorsch Affiliates Acquire NYC Shares Amidst Revenue Decline and Valuation Concerns

Insider purchases by entities tied to a 10% owner occur as the REIT reports a 40.7% drop in Q1 revenue and faces overvaluation flags.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
NYC

Entities linked to Nicholas S. Schorsch, a significant 10% shareholder in American Strategic Investment Co. (NASDAQ: NYC), have executed recent purchases of the company's Class A common stock. These transactions, totaling $54,740, took place between June 25 and June 29, 2026. The acquisitions occurred during a period when the stock price increased by 13%, reaching a current trading level of $9.36. This insider activity coincides with broader financial assessments indicating that NYC may be overvalued relative to its intrinsic fair value, alongside a company carrying a debt-to-equity ratio of 4.39 and a financial health score classified as weak. The insider buying follows a reported 40.7% year-over-year revenue decline for the first quarter of 2026, driven by strategic asset dispositions and a major property foreclosure. Despite the revenue drop, the company's net loss showed a marginal improvement compared to the same period last year. Investors are closely monitoring these developments as the commercial real estate sector navigates ongoing market challenges.

Schorsch Affiliates Acquire NYC Shares Amidst Revenue Decline and Valuation Concerns
NYC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Entities tied to 10% shareholder Nicholas S. Schorsch purchased $54,740 worth of NYC shares between June 25 and June 29, 2026, during a period when the stock price rose 13% to $9.36.
  • American Strategic Investment Co. reported a 40.7% year-over-year revenue decline in Q1 2026, driven by strategic asset dispositions and a major property foreclosure, though net loss improved slightly.
  • InvestingPro analysis flags NYC as overvalued relative to fair value, with a high debt-to-equity ratio of 4.39 and a "WEAK" financial health score, highlighting balance sheet risks in the current rate environment.

Entities affiliated with Nicholas S. Schorsch, who holds a ten percent ownership stake in American Strategic Investment Co. (NASDAQ: NYC), have recently executed purchases of the company's Class A common stock. The total value of these transactions reached $54,740. The acquisitions were completed within a five-day window spanning from June 25 to June 29, 2026. During this same timeframe, the stock price experienced a notable surge of 13%. As of the latest reporting, the shares are trading at $9.36.

On June 25, Bellevue Capital Partners, LLC (BCP) acquired 1,000 shares of Class A common stock. BCP is an entity for which Mr. Schorsch serves as the sole managing member, holding full voting and investment discretion. The weighted average purchase price for these shares was $8.39, with individual transaction prices ranging between $8.35 and $8.44.

Additional purchases by BCP occurred on June 29. On this date, the entity acquired 5,000 shares of Class A common stock. The weighted average price for these shares was $9.27, with individual transaction prices ranging from $8.84 to $9.43.

In a separate transaction on June 26, New York City Advisors, LLC received 251,703 fully-vested shares of Class A common stock. New York City Advisors, LLC serves as the external advisor to American Strategic Investment Co. The value of these issued shares was $2,106,754. The shares were issued at a price of $8.37 per share pursuant to the company's 2020 Advisor Omnibus Incentive Compensation Plan. Mr. Schorsch, through his control of BCP, is the ultimate controlling person of New York City Advisors, LLC, and holds voting and investment discretion over its securities.

Following these reported transactions, Mr. Schorsch directly owns 26,559 shares of American Strategic Investment Co. Class A common stock. The reporting persons are part of a group that may be deemed to collectively own more than 10% of the issuer's outstanding common stock.

The insider activity comes as InvestingPro analysis indicates the stock is currently overvalued relative to its Fair Value. The company carries a debt-to-equity ratio of 4.39 and maintains a "WEAK" financial health score.

In other recent news, American Strategic Investment Co. reported a substantial decrease in revenue for the first quarter of 2026. The company's revenue fell by 40.7% compared to the previous year, largely due to strategic asset dispositions and the foreclosure of a major property. Despite this revenue decline, the company's net loss showed a slight improvement from the same period last year. These developments reflect ongoing challenges in the commercial real estate market. The financial results highlight the impact of strategic decisions on the company's performance. While the company's stock price remained stable, the revenue drop is a significant point of concern. Investors and analysts will likely be watching closely for any further developments in the company's strategy and market conditions.

Risks

  • The company's "WEAK" financial health score and high debt-to-equity ratio of 4.39 suggest potential balance-sheet resilience challenges amid rising interest rates.
  • The 40.7% revenue decline in Q1 2026, caused by strategic asset dispositions and property foreclosure, indicates ongoing operational and market headwinds in the commercial real estate sector.
  • The stock is flagged as overvalued relative to its fair value, creating potential valuation risk for investors if market conditions do not support current price levels.

More from Insider Trading

Legend Biotech Executive Share Sale and Capital Raise Activity Jun 29, 2026 Capricor Therapeutics CFO Bergmann Executes $732k Share Sale Under Pre-Arranged Plan Jun 29, 2026 Capricor Therapeutics Executive Karen Krasney Executes $732K Stock Sale Under Pre-Arranged Plan Jun 29, 2026 Insight Holdings Group Liquidates $121.5 Million in Hinge Health Shares Under Pre-Arranged Plan Jun 29, 2026 Insight Entities Offload $38.1 Million in Hinge Health Stock Amid Executive Conversions Jun 29, 2026